Description: The second report of a continuous investigation of Group Accident and Health experience, including Hospital and Surgical Expense benefits.

Description: This article provides an overview of critical illness insurance: history, product description, and the three primary ways to offer critical illness coverage in the United States. This article also contains an illustration of an issue age premium rate calculation, as well as product features and rating applications specific to the various types of critical illness coverage.

Description: This paper is a primer for actuaries with limited experience in accessing and using public data sets. From Small Talk Newsletter, November 2005, Issue No. 25.

Description: This article discusses the problems in estimating the prevalence of HIV infection.

Description: The results of the Large Group Medical Claims Study will be presented. Twenty-six insurers participated and nearly 200,000 claims were studied. Factors of the study included plan type, deductible level, hospitals versus other charges, age and gender of claimant, diagnosis, and ZIP code. From the Record of the Society of Actuaries, Vol. 21, No. 3b.

Description: This is a review of the publication entitled 'Medicare: Health Insurance for the Aged, 1969: Geographic Indices of Reimbursement by State and County.' It is of value to health actuaries because it contains information as to the variation in health insurance claim costs by geographical areas within the United States.

Description: This is a discussion about senior citizens' policies and how they compare to other policies. From Transactions of Society of Actuaries 1962, Vol. 14 Pt. 2

Description: Through the sponsorship of the Robert Wood Johnson Foundation, The Society of Actuaries partnered with Wakely to use their health care data to study the effects of COVID-19 on overall health care claims for individuals with a COVID-19 diagnosis. The conclusion of the study is that individuals with COVID-19 claims had significant increases in health care costs leading up to their months of diagnosis, as well as in the months following their diagnosis. These effects were more pronounced for individuals who were hospitalized due to COVID-19 as well as for individuals with prior co-morbidities. Finally, the overall health care costs of these members plateaued at significantly higher levels than their pre-COVID baselines. In fact, all the main membership cohorts experienced claim levels that were at least 20% higher than their pre-COVID starting points.